-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
In-vitro Diagnostics Instruments Market to Record a CAGR of 7.95% | Technavio
In-vitro Diagnostics Instruments Market to Record a CAGR of 7.95% | Technavio
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The in-vitro diagnostics instruments market is expected to grow by USD 23.00 bn from 2020 to 2025, according to Technavio. The report offers an updated analysis of the present market scenario, the latest trends and drivers, and the overall market environment.
Fetch Free Sample Report to explore growth opportunities in the in-vitro diagnostics instruments market
Top 3 In-vitro Diagnostics Instruments Market Players
- Abbott Laboratories- The company offers in-vitro diagnostics instruments, namely Sapphire, Ruby, Emerald 22AL, and others.
- Becton Dickinson and Co.- The company offers in-vitro diagnostics instruments for mycobacteria testing and identification and susceptibility systems.
- Bio Rad Laboratories Inc.- The company offers in-vitro diagnostics instruments to screen microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
In-vitro Diagnostics Instruments Market 2021-2025: Segmentation
- Product
- Immunochemistry
- Clinical Microbiology
- Molecular Diagnostics
- Others
- End-user
- Hospitals And Diagnostic Laboratories
- Academic And Research Institutes
- Home Care
- Geography
- North America
- Europe
- Asia
- ROW
The in-vitro diagnostics instruments market is driven by the growing geriatric population, demand for personalized medicine, and product launches.
Download Our Free Sample for more information about market segmentation as well as the latest trends, drivers, and challenges
Reports that might interest you:
- Surgical Instruments Market: The surgical instruments market has been segmented by product (surgical sutures and stapling devices, handheld surgical devices, and electrosurgical devices) and geography (North America, Asia, Europe, and ROW). Download Free Sample Report
- Ventricular Assist Devices Market: The ventricular assist devices market has been segmented by product (left and right ventricular assist devices and bi-ventricular assist devices) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
In-vitro Diagnostics Instruments Market Scope | |
Report Coverage | Details |
Page number | 120 |
Base year | 2020 |
Forecast period | 2021-2025 |
Growth momentum & CAGR | Accelerate at a CAGR of 7.95% |
Market growth 2021-2025 | USD 23.00 billion |
Market structure | Fragmented |
YoY growth (%) | 6.23 |
Regional analysis | North America, Europe, Asia, and ROW |
Performing market contribution | North America at 35% |
Key consumer countries | US, China, Germany, Canada, and UK |
Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
Companies profiled | Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
Market Dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The in-vitro diagnostics instruments market is expected to grow by USD 23.00 bn from 2020 to 2025, according to Technavio. The report offers an updated analysis of the present market scenario, the latest trends and drivers, and the overall market environment.
紐約2021年11月25日/美通社/--根據Technavio的數據，從2020年到2025年，體外診斷儀器市場預計將增長23億美元。該報告對當前市場形勢、最新趨勢和驅動因素以及整體市場環境進行了最新分析。
Fetch Free Sample Report to explore growth opportunities in the in-vitro diagnostics instruments market
免費取樣報表探索體外診斷儀器市場的增長機會
Top 3 In-vitro Diagnostics Instruments Market Players
排名前3位的體外診斷儀器市場參與者
- Abbott Laboratories- The company offers in-vitro diagnostics instruments, namely Sapphire, Ruby, Emerald 22AL, and others.
- Becton Dickinson and Co.- The company offers in-vitro diagnostics instruments for mycobacteria testing and identification and susceptibility systems.
- Bio Rad Laboratories Inc.- The company offers in-vitro diagnostics instruments to screen microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
- 雅培-該公司提供體外診斷儀器，即藍寶石、紅寶石、翡翠22AL等。
- 貝頓·狄金森以及公司-該公司提供用於分枝桿菌檢測、鑑定和藥敏系統的體外診斷儀器。
- Bio Rad實驗室公司-該公司提供體外診斷儀器，以篩選微生物的存在，培養和鑑定生物體，並測試抗生素敏感性。
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
終身訪問我們的Technavio Insight。現在就訂閲我們最受歡迎的“Lite計劃”每年收費3000美元。每月查看3份報告，每年下載3份報告！
In-vitro Diagnostics Instruments Market 2021-2025: Segmentation
2021-2025年體外診斷儀器市場細分
- Product
- Immunochemistry
- Clinical Microbiology
- Molecular Diagnostics
- Others
- End-user
- Hospitals And Diagnostic Laboratories
- Academic And Research Institutes
- Home Care
- Geography
- North America
- Europe
- Asia
- ROW
- 產品
- 免疫化學
- 臨牀微生物學
- 分子診斷學
- 其他
- 最終用户
- 醫院和診斷實驗室
- 學術和研究機構
- 家庭護理
- 地理學
- 北美
- 歐洲
- 亞洲
- 劃
The in-vitro diagnostics instruments market is driven by the growing geriatric population, demand for personalized medicine, and product launches.
體外診斷儀器市場是由不斷增長的老年人口、對個性化藥物的需求以及產品發佈推動的。
Download Our Free Sample for more information about market segmentation as well as the latest trends, drivers, and challenges
下載我們的免費樣本有關細分市場以及最新趨勢、驅動因素和挑戰的更多信息
Reports that might interest you:
您可能感興趣的報告：
- Surgical Instruments Market: The surgical instruments market has been segmented by product (surgical sutures and stapling devices, handheld surgical devices, and electrosurgical devices) and geography (North America, Asia, Europe, and ROW). Download Free Sample Report
- Ventricular Assist Devices Market: The ventricular assist devices market has been segmented by product (left and right ventricular assist devices and bi-ventricular assist devices) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
- 手術器械市場：手術器械市場已按產品(手術縫合線和吻合器、手持手術器械和電外科器械)和地理位置(北美, 亞洲, 歐洲和ROW)。下載免費樣本報告
- 心室輔助設備市場：心室輔助設備市場已按產品(左、右心室輔助設備和雙心室輔助設備)和地域(北美, 歐洲, 亞洲和ROW)。下載免費樣本報告
|
In-vitro Diagnostics Instruments Market Scope | |
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.95% |
|
Market growth 2021-2025 |
USD 23.00 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
6.23 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 35% |
|
Key consumer countries |
US, China, Germany, Canada, and UK |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. |
|
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
|
體外診斷儀器的市場範圍 | |
|
報告覆蓋範圍 |
細節 |
|
頁碼 |
120 |
|
基準年 |
2020 |
|
預測期 |
2021-2025 |
|
增長動能與複合年增長率 |
以7.95%的複合年均增長率加速 |
|
2021-2025年市場增長 |
23億美元 |
|
市場結構 |
支離破碎 |
|
同比增長(%) |
6.23 |
|
區域分析 |
北美、歐洲、亞洲和ROW |
|
表演市場貢獻 |
北美為35% |
|
主要消費國 |
美國、中國、德國、加拿大和英國 |
|
競爭格局 |
領先公司、競爭戰略、消費者參與範圍 |
|
公司概況 |
雅培、Becton Dickinson和Co.、Bio Rad實驗室公司、Bio Merieux SA、Danaher Corp.、F.Hoffmann-La Roche Ltd.、HORIBA Ltd.、西門子股份公司、Sysmex Corp.和賽默飛世爾。 |
|
市場動態 |
母市場分析，市場增長誘因和障礙，快增長和慢增長細分市場分析，新冠肺炎影響和未來消費者動態，預測期市場狀況分析 |
|
定製權限 |
如果我們的報告沒有包括您正在尋找的數據，您可以聯繫我們的分析師並定製細分市場。 |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
關於我們
Technavio是一家全球領先的技術研究和諮詢公司。他們的研究和分析專注於新興市場趨勢，並提供可操作的見解，幫助企業識別市場機會並制定有效的戰略，以優化其市場地位。Technavio的報告庫擁有500多名專業分析師，由17000多份報告組成，並在不斷統計，涵蓋了橫跨50個國家和地區的800項技術。他們的客户羣包括各種規模的企業，其中包括100多家財富500強公司。不斷增長的客户基礎依賴於Technavio的全面覆蓋、廣泛的研究和可操作的市場洞察力，以確定現有和潛在市場中的機會，並評估它們在不斷變化的市場情景中的競爭地位。
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
聯繫人
技術研究
傑西·邁達
媒體與營銷主管
美國：+1 844 364 1100
英國：+44 203 893 3200
電子郵件：[受電子郵件保護]
網址：www.Technavio.com/
SOURCE Technavio
來源技術
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧